Effect of orchiectomy on renal function in control and diabetic rats with chronic inhibition of nitric oxide

Sharon Anderson1, Justin G Chapman, Terry T Oyama

  • 1Division of Nephrology and Hypertension, Oregon Health and Science University, Portland, Oregon 97239-2940, USA.

Insights

Testosterone deficiency (orchiectomy) showed minor benefits for proteinuria in normal rats but not in diabetic rats with inhibited nitric oxide (NO) production. This indicates testosterone reduction does not protect the diabetic kidney.

Area of Science:

  • Nephrology
  • Endocrinology
  • Urology

Background:

  • Male gender is linked to higher blood pressure (BP) and faster kidney function decline in diseases like diabetic nephropathy.
  • Modulating testosterone levels may offer protective effects for the diabetic kidney.

Purpose of the Study:

  • To investigate the influence of testosterone deficiency (orchiectomy) on BP and renal function in streptozotocin-diabetic rats.
  • To assess these effects with and without nitric oxide (NO) synthesis inhibition (using N(G)-nitro-L-arginine methyl ester [l-NAME]) in both diabetic and non-diabetic rats.

Main Methods:

  • Orchiectomy was performed on streptozotocin-diabetic and age-matched non-diabetic rats.
  • Rats received either l-NAME or a vehicle control in their drinking water for two weeks.
  • Blood pressure, proteinuria, renal plasma flow (RPF), and filtration fraction (FF) were measured.

Main Results:

  • Orchiectomy did not alter l-NAME-induced increases in BP in either diabetic or non-diabetic rats.
  • In non-diabetic rats, orchiectomy attenuated l-NAME-induced proteinuria; this effect was absent in diabetic rats.
  • While l-NAME reduced RPF in intact diabetic rats, this was not observed in orchiectomized diabetic rats, though they still showed impaired renal hemodynamics compared to controls.

Conclusions:

  • Orchiectomy provided modest benefits for proteinuria in normal rats with inhibited NO production, but not in diabetic rats.
  • Testosterone reduction does not mitigate the detrimental effects of the diabetic metabolic state on the kidney.